Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 175 results found. Search for [ Zydus coronavirus vaccine ]

Results 140 to 160 of 175
BusinessToday.In
New Delhi, May 30, 2020
Coronavirus vaccine update: Novavax is buying SII's manufacturing plant and planning to produce a billion doses of its coronavirus vaccine by next year


PB Jayakumar
May 27, 2020
Approval to explore new COVID-19 therapies, licensing and supply deals to manufacture drugs to treat the virus and fast approvals for plants under regulatory scanner have turned the fortunes of most of these companies


E Kumar Sharma
New Delhi, May 27, 2020
Coronavirus crisis: WHO is currently assessing the use of hydroxychloroquine on COVID-19 patients within the Solidarity Trial. The hydroxychloroquine arm of the trial has been paused as a precaution while the safety data is being reviewed.


BusinessToday.In
May 27, 2020
Stock Market LIVE Updates: HCL Tech, HDFC Bank, Maruti, IndusInd Bank, Bajaj Finance, Birla Corporation, MMTC, Meghmani Organics were among the top gainers. While ITC, Reliance Industries, M&M, Ultratech Cement, Asian Paints,  Titan and NTPC were among the top losers today


BusinessToday.In
New Delhi, May 23, 2020
Research on a COVID-19 vaccine in India is at a very early stage of development and candidates are likely to reach animal trials only by the end of the year, says leading virologist Shahid Jameel


BusinessToday.In
New Delhi, May 21, 2020
Earlier, the company had partnered with ICMR to be better equipped against infectious disease outbreaks, and help people, who are at high risk, particularly in distant, remote areas of the country


PB Jayakumar
May 11, 2020
Mumbai-based medical devices company Transasia Biomedical's German subsidiary Erba Mannheim has already got clearance from the US and Europe to make COVID-19 antibody ELISA kits


PTI
May 11, 2020
The Indian Council of Medical Research-National Institute of Virology, Pune, technology has been transferred to Zydus Cadila for mass-scale production


BusinessToday.In
May 9, 2020
Coronavirus vaccine: World leaders and organisations, except the United States, have already pledged $8 billion to research, manufacture and distribute a possible vaccine and treatments for COVID-19 apart from the individual efforts taken by the countries and its pharmaceutical firms


BusinessToday.In
New Delhi, May 7, 2020
The company is taking utmost care and precautions to safeguard the health of its employees across the country, Cadila said


BusinessToday.In
New Delhi, May 6, 2020
United States has been worst affected nation with 72,275 deaths, followed by the UK, Italy and Spain; as spread of coronavirus shows no sign of slowing down, researchers and various governments are doubling efforts to develop a vaccine


PB Jayakumar
May 6, 2020
Regulatory agencies have fast-tracked the vaccine development, which normally takes 7-10 years to reach the market


BusinessToday.In
New Delhi, May 5, 2020
Covid-19 Vaccine: Check latest news and updates on coronavirus vaccine, when will coronavirus vaccine be ready, all you need to know about coronavirus vaccine production


PB Jayakumar
April 29, 2020
The vaccine will be based on recombinant avian paramyxovirus based vector platform, which has been used in the past as a vaccine vector for various animals and human pathogens


PB Jayakumar and E Kumar Sharma
New Delhi, April 28, 2020
Seven Indian firms are among those hunting for a vaccine to tame Covid-19. Here is how the projects are progressing


PB Jayakumar
April 19, 2020
Department of Biotechnology (DBT) will be central coordinating authority of the task force; its main focus will be to set up a process for coronavirus vaccine development


PB Jayakumar
New Delhi, April 15, 2020
How healthcare, FMCG, pharma, petrochemical and IT companies will turn the capabilities acquired during the coronavirus crisis into new businesses in India and abroad


Pankaj Khelkar
April 11, 2020
Bajaj Auto MD Rajiv Bajaj said putting the country under lockdown is hindering herd immunity, which is the only protection against coronavirus till a vaccine is developed


E Kumar Sharma
April 9, 2020
New theories on coronavirus's impact on human body are emerging, on the basis of which new solutions and lines of treatment are being examined


BusinessToday.In
April 8, 2020
However, India may see a strong sequential recovery in the second half of the financial year 2020-21, Goldman Sachs said


PAGES 8 OF 9  6789